Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy

Phase 0 Terminated 2 enrolled University of Arizona National Cancer Institute (NCI) · collab

NaSingle-groupOpen-labelSupportive care

Summary

This early phase 1 trial studies the use of everolimus in restoring salivary gland function in participants with locally advanced head and neck cancer after concurrent chemoradiation or radiation therapy alone.

Timeline

Start: 2018-05-04
Primary completion: 2019-11-15
Completion: 2019-11-15

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Everolimus	Small molecule	—	Oral

Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy

Summary

Timeline

Drugs

Indications